Climb Bio, Inc.
CLYM
$2.33
-$0.15-6.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.67M | -20.78M | -8.42M | -8.90M | -54.89M |
| Total Depreciation and Amortization | 38.00K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 491.00K | 1.42M | 1.22M | 2.65M | 52.24M |
| Change in Net Operating Assets | -3.01M | 3.93M | 1.67M | -1.31M | 1.98M |
| Cash from Operations | -11.15M | -15.43M | -5.52M | -7.56M | -667.00K |
| Capital Expenditure | -77.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -4.65M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.86M | -42.75M | -53.41M | -71.79M | -5.00M |
| Cash from Investing | 4.79M | -42.75M | -53.41M | -71.79M | -9.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 291.00K | 2.27M | 128.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -250.00K | -- | -- |
| Cash from Financing | -- | -- | 41.00K | 2.27M | 128.40M |
| Foreign Exchange rate Adjustments | 24.00K | -24.00K | -57.00K | 108.00K | 19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.34M | -58.21M | -58.95M | -76.97M | 118.11M |